Literature DB >> 22102232

Expression, crystallization and preliminary X-ray characterization of the human epithelial cell-adhesion molecule ectodomain.

Miha Pavšič1, Brigita Lenarčič.   

Abstract

The epithelial cell-adhesion molecule (EpCAM; CD326) is a transmembrane glycoprotein involved in epithelial cell-cell adhesion, cell proliferation and differentiation. Its elevated expression level in various carcinomas is exploited by several antitumour therapies that are at various stages of clinical development. The 35 kDa polypeptide chain of EpCAM is divided into a large extracellular part, a transmembrane helix and a short cytoplasmic tail. The modular extracellular part of human EpCAM was cloned and mutated to prevent N-linked glycosylation. After expression in insect cells and purification using standard chromatographic techniques, the extracellular part was crystallized. The crystals belonged to space group C2, with unit-cell parameters a = 86.83, b = 50.16, c = 66.56 Å, β = 127.9°. The crystal diffracted to 1.95 Å resolution and contained one molecule in the asymmetric unit.
© 2011 International Union of Crystallography. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102232      PMCID: PMC3212451          DOI: 10.1107/S1744309111031897

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  22 in total

1.  Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas.

Authors:  Christof Pauli; Markus Münz; Cuong Kieu; Brigitte Mack; Peter Breinl; Barbara Wollenberg; Stephan Lang; Reinhard Zeidler; Olivier Gires
Journal:  Cancer Lett       Date:  2003-04-10       Impact factor: 8.679

Review 2.  Thyropins--new structurally related proteinase inhibitors.

Authors:  B Lenarcic; T Bevec
Journal:  Biol Chem       Date:  1998-02       Impact factor: 3.915

3.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

4.  Molecular cloning and characterization of a human adenocarcinoma/epithelial cell surface antigen complementary DNA.

Authors:  J Strnad; A E Hamilton; L S Beavers; G C Gamboa; L D Apelgren; L D Taber; J R Sportsman; T F Bumol; J D Sharp; R A Gadski
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

6.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Determination of disulfide bond assignments and N-glycosylation sites of the human gastrointestinal carcinoma antigen GA733-2 (CO17-1A, EGP, KS1-4, KSA, and Ep-CAM).

Authors:  J M Chong; D W Speicher
Journal:  J Biol Chem       Date:  2000-11-15       Impact factor: 5.157

8.  Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen.

Authors:  C P Strassburg; Y Kasai; B A Seng; P Miniou; J Zaloudik; D Herlyn; H Koprowski; A J Linnenbach
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

9.  Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells.

Authors:  Tung-Ying Lu; Ruei-Min Lu; Mei-Ying Liao; John Yu; Chu-Hung Chung; Cheng-Fu Kao; Han-Chung Wu
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

10.  C-terminal domain of insulin-like growth factor (IGF) binding protein-6: structure and interaction with IGF-II.

Authors:  Stephen J Headey; David W Keizer; Shenggen Yao; Geoffrey Brasier; Phillip Kantharidis; Leon A Bach; Raymond S Norton
Journal:  Mol Endocrinol       Date:  2004-08-12
View more
  7 in total

1.  Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM).

Authors:  Thanos Tsaktanis; Heidi Kremling; Miha Pavšič; Ricarda von Stackelberg; Brigitte Mack; Akio Fukumori; Harald Steiner; Franziska Vielmuth; Volker Spindler; Zhe Huang; Jasmine Jakubowski; Nikolas H Stoecklein; Elke Luxenburger; Kirsten Lauber; Brigita Lenarčič; Olivier Gires
Journal:  J Biol Chem       Date:  2015-08-19       Impact factor: 5.157

2.  EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition.

Authors:  Ya-Ting Hsu; Pawel Osmulski; Yao Wang; Yi-Wen Huang; Lu Liu; Jianhua Ruan; Victor X Jin; Nameer B Kirma; Maria E Gaczynska; Tim Hui-Ming Huang
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

3.  In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers.

Authors:  David R Bell; Jeffrey K Weber; Wang Yin; Tien Huynh; Wei Duan; Ruhong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-31       Impact factor: 11.205

4.  Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE.

Authors:  Tomaž Žagar; Miha Pavšič; Aljaž Gaber
Journal:  PeerJ       Date:  2021-05-21       Impact factor: 2.984

5.  Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.

Authors:  Narendra V Sankpal; Taylor C Brown; Timothy P Fleming; John M Herndon; Anusha A Amaravati; Allison N Loynd; William E Gillanders
Journal:  BMC Cancer       Date:  2021-05-12       Impact factor: 4.430

6.  Crystals on the cover 2012.

Authors:  Howard Einspahr; Manfred S Weiss
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-12-24

Review 7.  Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?

Authors:  Olivier Gires; Min Pan; Henrik Schinke; Martin Canis; Patrick A Baeuerle
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.